BSC
VYGR icon

BOLTON SECURITIES CORPORATION’s Voyager Therapeutics VYGR Stock Holding History

BOLTON SECURITIES CORPORATION’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.67K Buy
+1,000
New +$3.62K ﹤0.01% 1716
2025
Q1 		$3.38K Buy
+1,000
New +$4.67K ﹤0.01% 1651

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Armistice Capital
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vestal Point Capital
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Erste Asset Management
Erste Asset Management Vienna, Austria $13.7B AUM 40.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
EcoR1 Capital
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BOLTON SECURITIES CORPORATION's VYGR Position: Q3 2025 in Review

BOLTON SECURITIES CORPORATION opened a new position in Voyager Therapeutics (VYGR) in Q3 2025: 1,000 shares worth $4.67K. The stake represents ﹤0.01% of the portfolio and ranks #1716 among its holdings. This is a return to the name: BOLTON SECURITIES CORPORATION previously reported a position in VYGR as recently as Q1 2025.

BOLTON SECURITIES CORPORATION first reported a position in VYGR in Q1 2025 and has held it in 2 quarters since. 119 funds tracked by Wall St. Rank hold VYGR as of Q3 2025.

  • BOLTON SECURITIES CORPORATION held 1,000 shares of Voyager Therapeutics worth $4.67K as of Q3 2025.
  • Voyager Therapeutics was a new BOLTON SECURITIES CORPORATION position in Q3 2025.
  • Voyager Therapeutics made up ﹤0.01% of BOLTON SECURITIES CORPORATION's portfolio in Q3 2025, its #1716 holding.
  • BOLTON SECURITIES CORPORATION first reported a position in Voyager Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 119 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q3 2025.

Based on BOLTON SECURITIES CORPORATION's 13F filing for Q3 2025, filed 12 Nov 2026.